TWIK-2 (Two-Pore Domain Potassium Channel 2), encoded by the KCNK6 gene, is a member of the two-pore domain potassium (K2P) channel family. While originally characterized in peripheral tissues, emerging research suggests potential roles for TWIK-2 and related K2P channels in neuroinflammation and glial cell function relevant to neurodegenerative diseases including Alzheimer's Disease (AD) and Parkinson's Disease (PD) [1][2].
| Two-Pore Domain Potassium Channel 6 (TWIK-2) |
|---|
| Protein Name | TWIK-2 (K2P6.1) |
| Gene | KCNK6 |
| UniProt ID | Q9Y5S1 |
| Molecular Weight | ~45 kDa |
| Subcellular Localization | Plasma membrane |
| Protein Family | Two-pore domain potassium channel (K2P) family |
| Brain Expression | Moderate - [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation) |
TWIK-2 is a member of the two-pore domain potassium channel family with the characteristic four transmembrane segments and two pore domains (P1 and P2). The channel forms functional homodimers, each subunit containing:
- Four transmembrane helices (M1-M4)
- Two pore domains (P1 and P2) with the K⁺ selectivity filter motif GYG
- Extracellular loop between M1 and P1
- Intracellular N- and C-termini
TWIK-2 channels are modulated by:
- pH: Sensitive to intracellular pH changes
- Voltage: Weakly voltage-dependent background current
- Lipids: Modulated by phospholipids and arachidonic acid
- Hypoxia: Regulated by oxygen-sensing mechanisms
In the central nervous system, TWIK-2 contributes to background potassium conductance (leak current) that helps maintain neuronal and glial resting membrane potential. Under normal conditions:
- Neuronal homeostasis: Helps maintain resting membrane potential in neurons
- Glial function: Expressed in astrocytes and microglia, contributing to K⁺ buffering
- Neurotransmitter regulation: Influences GABAergic and glutamatergic signaling
- Cell volume regulation: Participates in regulatory volume decrease
TWIK-2 and related K2P channels (particularly TWIK-1 and TREK-1) have been implicated in microglial activation and neuroinflammation:
- Microglial priming: K2P channels regulate microglial membrane potential; their modulation can influence pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6)
- NLRP3 inflammasome: Some K2P channels interact with innate immune signaling pathways
- Oxidative stress: Channel dysfunction may exacerbate reactive oxygen species (ROS) production
While direct evidence for TWIK-2 in AD is limited, related mechanisms suggest potential involvement:
- Amyloid-beta (Aβ) oligomers can alter glial potassium homeostasis
- Aβ-induced membrane depolarization may involve K2P channel modulation
- Neuroinflammation driven by microglial K2P dysfunction could accelerate tau pathology
Potential connections to PD include:
- Alpha-synuclein aggregation may affect microglial K⁺ channel function
- K2P channel modulators could influence dopaminergic neuron survival
- Neuroinflammation in PD substantia nigra involves glial potassium handling
TWIK-2 and related K2P channels represent emerging therapeutic targets:
| Target |
Compound Class |
Therapeutic Rationale |
| K2P channels |
Flavanoids |
Neuroprotective via anti-inflammatory effects |
| TWIK-1/TREK |
ML265, riluzole |
Modulate microglial activation |
| General K2P |
Halogenated ethers |
Neuroprotection in ischemia |
- Selectivity: Developing TWIK-2-specific modulators is challenging due to high homology within K2P family
- Blood-brain barrier: Ensuring CNS penetration of K2P modulators
- Homeostatic balance: K2P channels are essential for normal neuronal function; complete inhibition may be detrimental
While no TWIK-2-targeted drugs are in clinical use for neurodegenerative diseases, the channel is relevant in:
- Ischemic stroke: K2P channel dysfunction contributes to neuronal death
- Traumatic brain injury: Modulation of inflammatory response
- Aging: Age-related changes in K2P channel expression
- Patel AJ et al. A mammalian two-pore domain potassium channel. J Biol Chem. 1998
- Gray AT et al. TWIK-2, a pH-sensitive tandem pore domain potassium channel. J Immunol. 2003
- Heurteaux C et al. TREK-1, a neuroprotective K2P channel. CNS Drugs. 2006
- Miller BA, et al. K2P channels in neuroinflammation. J Neuroinflammation. 2020